Injectable healing protocol: Dose: 2-3mg daily (higher end of range) Frequency: Daily throughout healing period Duration: Until wound resolves plus 1-2 weeks Injection site: Systemic (not into wound) Topical healing protocol: Concentration: 2-4% in wound-appropriate vehicle Application: 2-3 times daily to wound margins (not directly into open wounds) Duration: Throughout healing process Note: Consult healthcare provider for significant wounds GHK-CU pairs exceptionally well with BPC-157 and TB-500 for wound healing
S.SkyggebjergR
Patients considering oral BPC-157 should understand that the human clinical trial record is limited: the evidence is primarily preclinical, and physician assessment of their specific GI condition is essential before starting any protocol
Whatever your situation, whether you are an athlete pushing your limits, someone who suffers from chronic pain, or just someone who wants to live an active life, BPC-157 offers a promising solution
The molecule has been studied in animal models of adipose-tissue metabolism, with published preclinical work examining its effects on NAD+ pool dynamics and on the methyl-donor balance NNMT regulates
A 2026 neuroscience review of REM, BDNF/HGF synaptic homeostasis, memory consolidation & a practical sleep protocol